CoChat

NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase

Open access
Yang, Yue, Zhang, Ning, Zhang, Guoan, Sauve, Anthony A. · 2020 · Nature Metabolism
Cited by 75

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Dihydronicotinamide riboside (NRH) has been suggested to act as a precursor for the synthesis of NAD+, but the biochemical pathway converting it has been unknown. Here, we show that NRH can be converted into NAD+ via a salvage pathway in which adenosine kinase (ADK, also known as AK) acts as an NRH kinase. Using isotope-labelling approaches, we demonstrate that NRH is fully incorporated into NAD+, with NMNH acting as an intermediate. We further show that AK is enriched in fractions from cell lysates with NRH kinase activity, and that AK can convert NRH into NAD+. In cultured cells and mouse liver, pharmacological or genetic inhibition of AK blocks formation of reduced nicotinamide mononucleotide (NMNH) and inhibits NRH-stimulated NAD+ biosynthesis. Finally, we confirm the presence of endogenous NRH in the liver with metabolomics. Our findings establish NRH as a natural precursor of NAD+ and reveal a new route for NAD+ biosynthesis via an NRH salvage pathway involving AK. Yang et al. report that adenosine kinase possesses NRH kinase activity that enables it to convert NRH into NAD+, thus revealing a new salvage pathway for NAD+ biosynthesis operating in mammalian cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42255-020-0194-9

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 29

  1. Yang, Y. & Sauve, A. A. NAD+ metabolism: bioenergetics, signaling and manipulation for therapy. Biochim. Biophys. Acta 1864, 1787–1800 (2016). · DOI · Paper page
  2. Rajakumar, K. Pellagra in the United States: a historical perspective. South Med. J. 93, 272–277 (2000). · DOI
  3. Wilder, R. M. A brief history of the enrichment of flour and bread. JAMA 162, 1539–1541 (1956). · doi:10.1001/jama.1956.72970340006010
  4. Kornberg, A. & Lindberg, O. DPN pyrophosphatase. Fed. Proc. 7, 165 (1948).
  5. Kornberg, A. The participation of inorganic pyrophosphate in the reversible enzymatic synthesis of diphosphopyridine nucleotide. J. Biol. Chem. 176, 1475 (1948). · DOI · Paper page
  6. Preiss, J. & Handler, P. Enzymatic synthesis of nicotinamide mononucleotide. J. Biol. Chem. 225, 759–770 (1957). · DOI · Paper page
  7. Preiss, J. & Handler, P. Biosynthesis of diphosphopyridine nucleotide. II. Enzymatic aspects. J. Biol. Chem. 233, 493–500 (1958). · DOI · Paper page
  8. Preiss, J. & Handler, P. Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates. J. Biol. Chem. 233, 488–492 (1958).. · DOI · Paper page
  9. Bogan, K. L. & Brenner, C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu. Rev. Nutr. 28, 115–130 (2008). · DOI · Paper page
  10. Sauve, A. A. NAD+ and vitamin B3: from metabolism to therapies. J. Pharmacol. Exp. Ther. 324, 883–893 (2008). · DOI · Paper page
  11. Gholson, R. K., Ueda, I., Ogasawara, N. & Henderson, L. M. The enzymatic conversion of quinolinate to nicotinic acid mononucleotide in mammalian liver. J. Biol. Chem. 239, 1208–1214 (1964). · DOI
  12. Nishizuka, Y. & Hayaishi, O. Enzymic synthesis of niacin nucleotides from 3-hydroxyanthranilic acid in mammalian liver. J. Biol. Chem. 238, 483–485 (1963). · DOI
  13. Gomes, A. P. et al. Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging. Cell 155, 1624–1638 (2013). · DOI · Paper page
  14. Katsyuba, E. & Auwerx, J. Modulating NAD+ metabolism, from bench to bedside. EMBO J. 36, 2670–2683 (2017). · DOI · Paper page
  15. Barbosa, M. T. et al. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J. 21, 3629–3639 (2007). · DOI · Paper page
  16. Gong, B. et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-gamma coactivator 1alpha regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer’s mouse models. Neurobiol. Aging 34, 1581–1588 (2013). · DOI · Paper page
  17. Xu, W. et al. Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Rep. 13, 533–545 (2015). · DOI · Paper page
  18. Zhang, R. et al. Short-term administration of nicotinamide mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure. J. Mol. Cell Cardiol. 112, 64–73 (2017). · DOI
  19. Tummala, K. S. et al. Inhibition of de novo NAD+ synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. Cancer Cell 26, 826–839 (2014). · DOI · Paper page
  20. Airhart, S. E. et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. PLoS One 12, e0186459 (2017). · DOI · Paper page
  21. Yang, Y., Mohammed, F. S., Zhang, N. & Sauve, A. A. Dihydronicotinamide riboside is a potent NAD+ concentration enhancer in vitro and in vivo. J. Biol. Chem. 294, 9295–9307 (2019). · DOI · Paper page
  22. Megarity, C. F. et al. The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties. FEBS Lett. 588, 1666–1672 (2014). · DOI
  23. Miller, R. L. et al. Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity. J. Biol. Chem. 254, 2346–2352 (1979).
  24. Ugarkar, B. G. et al. Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analogues. J. Med. Chem. 43, 2883–2893 (2000). · doi:10.1021/jm000024g
  25. Jarvis, M. F. et al. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse. J. Pharmacol. Exp. Ther. 295, 1156–1164 (2000).
  26. Giroud-Gerbetant, J. et al. A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor. Mol. Metab. 30, 192–202 (2019). · DOI · Paper page
  27. Boison, D. & Yegutkin, G. G. Adenosine metabolism: emerging concepts for cancer therapy. Cancer Cell 36, 582–596 (2019). · DOI · Paper page
  28. Yang, T., Chan, N. Y. & Sauve, A. A. Syntheses of nicotinamide riboside and derivatives: effective agents for increasing nicotinamide adenine dinucleotide concentrations in mammalian cells. J. Med. Chem. 50, 6458–6461 (2007). · DOI
  29. Li, W. & Sauve, A. A. NAD+ content and its role in mitochondria. Methods Mol. Biol. 1241, 39–48 (2015). · DOI

Cited by

See all 75

Metadata

Authors
Yang, Y., Zhang, N., Zhang, G., & Sauve, A. A.
Venue
Nature Metabolism
Published
2020-04-21
Volume
2
Issue
4
Pages
364-379
ISSN
2522-5812 (ISSN-L)
OpenAlex
W3019213887
Cited by
75
References
16
FWCI
5.30
Type
journal article
Language
en
Open access
green
Licence
Funders
  • U.S. Department of Health & Human Services | National Institutes of Health (GM R01-106072)
  • New York State Department of Health - Wadsworth Center (C32098GG)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase. https://app.cochat.ai/papers/10.1038/s42255-020-0194-9
The paper
Yang, Y., Zhang, N., Zhang, G., & Sauve, A. A. (2020). NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase. Nature Metabolism. https://doi.org/10.1038/s42255-020-0194-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.